Serafin, Retchel Mae E.
HRN: 02-25-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 1.5GM (VIAL)
12/27/2022
01/03/2023
IVTT
1.3g
Q8
UTI;URTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes